The Effect of a Healthy Snack on Radiance, Aging and Inflammation of the Skin
AlmondSkin
Clinical Trial to Determine the Efficacy of Almonds for Skin Radiance, Inflammation and Aging in Asian Females: A Pilot Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The anti-oxidative and anti-inflammatory effects of polyphenolic compounds of almonds have been reported in limited animal studies and may have the potential to improve skin radiance. However, the skin related beneficial properties of almonds have not been investigated in humans. This study will examine the effects of almond consumption on human skin radiance in Asian women as a pilot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2020
CompletedFirst Submitted
Initial submission to the registry
April 9, 2020
CompletedFirst Posted
Study publicly available on registry
April 20, 2020
CompletedApril 20, 2020
April 1, 2020
6 months
April 9, 2020
April 16, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin radiance
Determine the clinical efficacy of almond consumption on skin radiance. The main criteria will be evaluated by clinical scoring using the coloring, luminosity, brightness, and transparency (C.L.B.T.TM)(18) scale and imperfections scale (dark circles, redness/rosacea, spots, and heterogeneity). The C.L.B.T.TM methodology allows assessing different descriptors of the complexion: coloring, luminosity, brightness, and transparency of facial skin.
12 weeks
Secondary Outcomes (2)
UV radiation sensitivity
12 weeks
Skin aging (elasticity, sebum, and hydration/moisture)
12 weeks
Study Arms (2)
Almonds
EXPERIMENTALConsume 1.5 oz. serving almonds (246 calories) daily for 12 weeks
Pretzels
ACTIVE COMPARATORConsume 2 oz. serving pretzels (216 calories) daily for 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Healthy Asian females age 18-50 years' old (inclusive)
- Typically consume low fiber/polyphenol diet (beige diet)
- In good health with a BMI of 22 to 30 kg/ m2 (inclusive)
- Non-smokers
- Fitzpatrick Skin type II-IV
- Willing to maintain their normal skin care pattern for the duration of the study
- Willing to maintain their normal diet for the duration of the study but avoid almonds and pretzels.
- Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.
You may not qualify if:
- Eating a high fiber/polyphenol diet or taking any medication or dietary supplement which interfere with the absorption of polyphenols.
- Women who are pregnant, lactating or trying to become pregnant.
- Currently taking any skin related prescription medication or supplements for less than 3 months.
- Currently consuming \>14 alcoholic drinks (1 drink = 12 fl oz beer, 4 fl oz wine or 1.5 fl oz liquor) per week and/or unwilling to limit intake to less than 3 drinks per week during study participation or history of alcohol dependency.
- Screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
- History or current diagnosis of serious medical condition such as Type I or Type II diabetes, major surgery, thyroid disease, heart problems (e.g. angina, bypass surgery, myocardial infarction, etc.), presence of implanted cardiac defibrillator or pacemaker, uncontrolled hypertension/high blood pressure, gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer disease, Crohn's disease, chronic diarrhea or active gallbladder disease, inflammatory bowel disease, fatty liver or cancer.
- Known allergy to almonds.
- Participation in another clinical trial within 30 days prior to enrollment.
- Any known clinically significant food allergy or intolerance.
- Currently taking any prescription medication or supplements for less than 3 months.
- Is unable or unwilling to comply with the study protocol.
- Subjects who cannot avoid excessive exposure to either natural or artificial sunlight.
- Received a nasally-delivered steroid, antibiotics within the past 14 days.
- Used topical antibiotic or topical steroid on the face,currently taking any prescription medications that increase the risk of photosensitivity or history of taking such medications in the less than 3 months (e.g. alpha-hydroxy acids in cosmetics, antibiotics (ciprofloxacin, doxycycline, levofloxacin, ofloxacin, tetracycline, trimethoprim), antifungals (flucytosine, griseofulvin, voriconazole), antihistamines (cetirizine, diphenhydramine, loratadine, promethazine, cyproheptadine)
- Subjects with a significant medical history or concurrent condition that the investigator(s) feel is not safe for the study
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Los Angeleslead
- Almond Board of Californiacollaborator
Study Sites (1)
UCLA Center for Human Nutrition
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhaoping Li
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
April 9, 2020
First Posted
April 20, 2020
Study Start
July 25, 2019
Primary Completion
January 23, 2020
Study Completion
January 23, 2020
Last Updated
April 20, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share